Advertisement

Topics

Network Synergy Group Company Profile

04:28 EST 17th December 2018 | BioPortfolio

Network Synergy Group, a wholly-owned subsidiary of GENEX Services, Inc., is a national physical therapy management company founded in 1997. The company offers a comprehensive and outcome-based approach to managing workers’ compensation physical therapy claims. The company’s goal is to ensure greater accountability, more collaboration and communication among providers, file managers and injured workers, and to deliver lower costs and superior results. For more information visit www.network-synergy.com or call 813-207-0727.


News Articles [1130 Associated News Articles listed on BioPortfolio]

Synergy Pharmaceuticals Announces License Agreement with Luoxin Pharmaceutical Group for TRULANCE (plecanatide) in China

Synergy Pharmaceuticals (NASDAQ:SGYP) announced today that the company has entered into a license agreement with Luoxin Pharmaceutical Group Shandong (Luoxin) providing Luoxin exclusive rights to deve...

Barcelona researchers win one of the most prestigious EU grants to study CLL

The European Research Council today announced the results of the 2018 Synergy Grants call for proposals. The aim of Synergy Grants is to address ambitious research questions that can only be answered ...

Bausch Health Enters into a Definitive Agreement to Acquire Certain Assets of Synergy Pharmaceuticals

LAVAL, Quebec, Dec. 12, 2018 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) announced today that it has entered into a def...

Luoxin gets Trulance rights in China from Synergy

Synergy Pharmaceuticals Inc. granted Shandong Luoxin Pharmaceutical Group Co. Ltd. (Luoxin) exclusive rights to develop and sell Trulance (plecanatide) for chronic idiopathic constipation and constipa...

Synergy Billing Launches Revenue Recovery Service with No Long-Term Contract to Convert At-Risk ...

DAYTONA BEACH, Fla., Sept. 5, 2018 /PRNewswire/ -- Synergy Billing announced today that the company is launching the Synergy Revenue Recovery Service. The launch took Read more...

Synergy Investment Group Has A New Target: The Shorts

To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health

Synergy Pharmaceuticals has spent years looking for a buyer. The developer of a struggling drug for two types of chronic constipation finally has one—now that it’s gone bankrupt. New York-base...

Activist Group Strikes Down Key Proposals At Synergy Pharma

PubMed Articles [3236 Associated PubMed Articles listed on BioPortfolio]

The cooperation of pharmacologic-dose ascorbate with ceftriaxone against Staphylococcus aureus through bactericidal synergy and enhanced macrophage killing activity.

Ascorbate is a low-cost compound with a known bactericidal-synergy to antibitics. However, the synergy depends on concentrations and organisms. Thus, the synergy test by time-kill assay might be appro...

Predict effective drug combination by deep belief network and Ontology Fingerprints.

The synergistic effect of drug combination is one of the most desirable properties for treating cancer. However, systematically predicting effective drug combination is a significant challenge. We rep...

Adaptation of kinematic synergy and postural control to mechanical ankle constraint on an unsteady stance surface.

Joint constraint interferes with the coordinative structure in joint movements used to optimize postural stability. This study aimed to investigate changes in postural synergy when the ankle joints we...

Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry.

The clinical performance of the SYNERGY drug-eluting stent (DES) in patients with acute myocardial infarction (MI) has not been investigated in detail. We sought to report on the outcomes after SYNERG...

Differences in motor network dynamics during recovery between supra- and infra-tentorial ischemic strokes.

Most previous stroke studies have been performed in heterogeneous patient populations. Moreover, the brain network might demonstrate different recovery dynamics according to lesion location. In this s...

Clinical Trials [4945 Associated Clinical Trials listed on BioPortfolio]

A 2x2 Factorial Randomized Controlled Trial of Colchicine and Spironolactone in Patients With STEMI Who Have Undergone PCI With SYNERGY Stent Registry

The CLEAR SYNERGY trial will study the long term effects of three multidisciplinary treatments following PCI to treat ST elevation myocardial infarction. These treatments address both the ...

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction

To assess strut coverage in patients presenting an acute myocardial infarction and treated either with the SYNERGY stent or the Bioresorbable Vascular Scaffold, through a parallel group de...

IRIS-Synergy Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.

Safety and Performance Evaluation of CircuLite Synergy

The purpose of the study is to demonstrate the safety and functionality of the CircuLite Synergy Pocket Circulatory Assist Device.

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

The lack of non-overlapping toxicities between the two drugs, the ease of all oral drug administration, and the possibility for antitumor synergy make exploration of this combination regim...

Companies [2341 Associated Companies listed on BioPortfolio]

Network Synergy Group

Network Synergy Group, a wholly-owned subsidiary of GENEX Services, Inc., is a national physical therapy management company founded in 1997. The company offers a comprehensive and...

Synergy Health Concepts

The team at Pacific Interventionalists launched Synergy Health Concepts to focus specifically on CCSVI treatment and care. Chronic Cerebro-Spinal Venous Insufficiency (CCSVI) is c...

Synergy Strips Corp.

Synergy Strips Corp. (OTCQB:SNYR) is a consumer health care company, that is in the process of building a portfolio of best-in- class consumer product brands. Synergy's strategy i...

Synergy Pharmaceuticals, Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug SP-304 is a synthetic a...

Synergy Research Inc.

Synergy Research was found in 1997. It is a privately held company. Centrally located in Northern New Jersey. Synergy Research is all about bringing together the necessary talent and resources, combin...

More Information about "Network Synergy Group" on BioPortfolio

We have published hundreds of Network Synergy Group news stories on BioPortfolio along with dozens of Network Synergy Group Clinical Trials and PubMed Articles about Network Synergy Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Network Synergy Group Companies in our database. You can also find out about relevant Network Synergy Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record